Fri, Dec 20, 2024
Hamps Bio’s shares soar with a 90% premium debut on BSE SME; IPO oversubscribed 1000 times, showcasing robust investor confidence in the pharmaceutical and FMCG player’s growth potential.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.